Progress in ensuring adequate access to internationally controlled substances for medical and scientific purposes

Preface
Contents
Executive Summary
Chapter I
Factors limiting the availability of narcotic drugs and psychotropic substances
Chapter II
Unbalanced increase in availability for consumption
|
Français Español عربي Русский 中文 |
Chapter III
Psychotropic substances (full chapter)
Global burden of disease and mental health disorders
|
Chapter IV
Implementation of recommendations made by the Board and of the recommendations contained in the outcome document of the special session of the General Assembly on the world drug problem held in 2016
A.
Member States
B.
Civil society organizations
C.
International community
Chapter V
Conclusions and the way ahead